These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Optical coherence tomography in STEMI with bioresorbable scaffold: possible cause of coronary flow impairment? A sub-study from the Prague 19 trial. Loffi M; Tousek P; Budesinsky T; Lisa L; Santangelo A; Widimsky P; Kocka V Heart Vessels; 2018 Nov; 33(11):1282-1287. PubMed ID: 29777297 [TBL] [Abstract][Full Text] [Related]
29. Predictors of acute scaffold recoil after implantation of the everolimus-eluting bioresorbable scaffold: an optical coherence tomography assessment in native coronary arteries. Sato T; Jose J; El-Mawardy M; Sulimov DS; Tölg R; Richardt G; Abdel-Wahab M Int J Cardiovasc Imaging; 2017 Feb; 33(2):145-152. PubMed ID: 27761749 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Serruys PW; Onuma Y; Ormiston JA; de Bruyne B; Regar E; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Miquel-Hebert K; Rapoza R; García-García HM Circulation; 2010 Nov; 122(22):2301-12. PubMed ID: 21098436 [TBL] [Abstract][Full Text] [Related]
31. Neointimal coverage and late apposition of everolimus-eluting bioresorbable scaffolds implanted in the acute phase of myocardial infarction: OCT data from the PRAGUE-19 study. Toušek P; Kočka V; Malý M; Lisa L; Buděšínský T; Widimský P Heart Vessels; 2016 Jun; 31(6):841-5. PubMed ID: 25896128 [TBL] [Abstract][Full Text] [Related]
32. Subclinical very late thrombus formation inside and outside the everolimus-eluting stent implanted 3 years prior in a patient with provoked coronary spasms. Ito S; Ohmori H Cardiovasc Interv Ther; 2017 Jan; 32(1):72-76. PubMed ID: 26660342 [TBL] [Abstract][Full Text] [Related]
33. Progressive growth of coronary aneurysms after bioresorbable vascular scaffold implantation: Successful treatment with OCT-guided exclusion using covered stents. Fabbiocchi F; Calligaris G; Bartorelli AL Catheter Cardiovasc Interv; 2021 Apr; 97(5):E676-E679. PubMed ID: 32744772 [TBL] [Abstract][Full Text] [Related]
34. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532 [TBL] [Abstract][Full Text] [Related]
35. Three-month evaluation of strut healing using a novel optical coherence tomography analytical method following bioresorbable polymer everolimus-eluting stent implantation in humans: the TIMELESS study. Vesga B; Hernandez H; Moncada M; Gasior P; Higuera S; Dager A; Arana C; Delgado JA; Généreux P; Maehara A; Granada JF Coron Artery Dis; 2017 Mar; 28(2):126-134. PubMed ID: 27879518 [TBL] [Abstract][Full Text] [Related]
39. Comparison of neointimal coverage and extra-stent lumen between sirolimus and everolimus-eluting stent using optical coherence tomography. Oda T; Okamura T; Yamada J; Miyagi N; Uehara H; Nao T; Tateishi H; Maeda T; Nakamura T; Shiraishi K; Nakashima T; Nishimura S; Miura T; Matsuzaki M; Yano M Heart Vessels; 2016 Apr; 31(4):449-56. PubMed ID: 25614415 [TBL] [Abstract][Full Text] [Related]
40. Intraluminal bioresorbable vascular scaffold dismantling with aneurysm formation leading to very late thrombosis. Patel A; Nazif T; Stone GW; Ali ZA Catheter Cardiovasc Interv; 2017 Apr; 89(5):876-879. PubMed ID: 28145045 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]